Optimal stroke prevention in patients with PFO

Lancet Neurol. 2019 Mar;18(3):231. doi: 10.1016/S1474-4422(19)30017-1. Epub 2019 Feb 12.

Authors

Maurizio Melis¹, Stefano Ricci², Danilo Toni³; editorial committee of the Italian National Guidelines on Stroke

Affiliations

¹ Neurology and Stroke Unit, Neuroscience and Rehabilitation Department, Azienda Ospedaliera G Brotzu, Cagliari 09134, Italy. Electronic address: mauriziomelis@aob.it.
² Neurology Unit, USL Umbria 1, Città di Castello, Italy.
³ Neurovascular Treatment Unit, Department of Human Neurosciences, Sapienza University, Rome, Italy.

PMID: 30784551
DOI: 10.1016/S1474-4422(19)30017-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Aspirin
Foramen Ovale, Patent*
Humans
Recurrence
Rivaroxaban
Stroke*

Substances

Rivaroxaban
Aspirin